HFF-ED: Reducing Readmission for Frail Elderly Patients With Decompensated Heart Failure

Sponsor
Jewish General Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03246035
Collaborator
Canadian Association of Emergency Physicians (Industry)
60
1
2
39
1.5

Study Details

Study Description

Brief Summary

A randomized study designed to determine whether telephone based interventions can prevent return hospital visits for elderly and frail patients with acute symptoms of heart failure. Specifically, the intervention will improve patients ability to monitor and address self care of heart failure at home.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Intervention Group
  • Other: Control Group (Standard Care)
N/A

Detailed Description

Acute decompensated heart failure (ADHF) is a common illness in Canadian emergency departments (ED). The frail subset of elderly patients with ADHF is challenging to treat, use a large proportion of available resources, and are at higher risk for complications, including readmission to hospital after discharge. The investigators believe that by improving access to follow-up, optimizing self-care, and addressing the various cognitive and physical limitations of frailty, it will be possible to improve quality of life and reduce readmission rates for frail patients with ADHF.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
A Prospective Randomized Pilot Trial to Reduce Readmission for Frail Elderly Patients With Acute Decompensated Heart Failure
Actual Study Start Date :
Mar 1, 2018
Anticipated Primary Completion Date :
Oct 1, 2020
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Control Group (Standard Care)

The control group will receive outpatient follow-up, medication advice and lifestyle guidance as prescribed at discharge from the ED or hospital.

Other: Control Group (Standard Care)
For patients randomized to the Control Group (Standard Care), they will receive their follow-up visits, medications, diet and physical activity advice as they normally would. This is the care they would receive even if they were not enrolled in the study

Experimental: Intervention Group

The intervention will consist of contacting the patient 5 days post-discharge and arranging definitive outpatient follow-up and providing targeted medical and lifestyle advice based on deficient domains identified at baseline.

Behavioral: Intervention Group
For the intervention arm, a specialized heart failure nurse practitioner will contact the patient or their primary caregiver by telephone within 5 days post-discharge and send them an education packet by mail. During the telephone call, the nurse will (1) confirm the patient's scheduled follow-up appointment in cardiology, (2) provide recommendations for heart failure self-care behaviors that were found to be deficient at baseline. Patients will then be referred to a Geriatrics Assessment Team, who will provide individualized recommendations for frailty domains that were found to be deficient at baseline. The technique used to provide educational recommendations will be motivational interviewing.

Outcome Measures

Primary Outcome Measures

  1. Primary Outcome - Re-admission rate to hospital for any diagnosis within 1 year of enrollment [1 year]

    The incidence of patients who present to any hospital and require admission for any diagnosis over a 1 year period

Secondary Outcome Measures

  1. Rate of return visits to any ER for any medical issue [30 days]

    Number of times enrolled patient visits an emergency department for any medical issue, over the 90 day follow-up period.

  2. Rate of admission to hospital at 90 days [90 days]

    Number of times the patient needs to be admitted to hospital for any medical issue, over the 3 month follow-up period.

  3. Incidence of adverse effects from medication [90 days]

    Number of patients who experience unexpected side effects from their heart failure medications

  4. Self-Care Index [90 days]

    Change in the Self-Care Heart Failure Index from enrollment to follow-up

  5. Heart Failure Symptom Scale [90 days]

    Change in the 12 point Heart Failure Symptom Scale from enrollment to follow-up

  6. Frailty Index [90 days]

    Change in the Frailty Index from enrollment to follow-up

  7. Recruitment rate [90 days]

    The number of eligible of patients recruited into the study over a 3 month trial period

  8. Attrition rate [90 days]

    The number of patients enrolled the study who choose to leave the study before completing the follow-up

  9. Informed consent validation (qualitative) [90 days]

    Qualitative feedback from participants regarding the informed consent process

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients who presented to the ED and who are being discharged with a primary or secondary diagnosis of ADHF

  • Age ≥ 65

  • Frailty, defined as a FRAIL score >=3/5 or Clinical Frailty Scale (CFS) score >=5/9

  • Informed consent provided by the patient or proxy

Exclusion Criteria:
  • Significant dementia or active delirium

  • Severe frailty, defined as a CFS score >=8/9

  • Prohibitive language barrier

  • Primary address outside of Quebec

  • Patient deemed to be palliative or moribund by treating team

Contacts and Locations

Locations

Site City State Country Postal Code
1 Jewish General Hospital Montréal Quebec Canada H3T 1E2

Sponsors and Collaborators

  • Jewish General Hospital
  • Canadian Association of Emergency Physicians

Investigators

  • Principal Investigator: Jonathan Afilalo, FRCPC, Assistant Professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rohit Mohindra, Researcher, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT03246035
Other Study ID Numbers:
  • ADHF-ED-JGH
First Posted:
Aug 11, 2017
Last Update Posted:
Jul 29, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Rohit Mohindra, Researcher, Jewish General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2020